Top

American Journal of Clinical Dermatology

Published in:

01-12-2011 | Guest Editorial

Evidence-Based Dermatology

Everyone’s Business

Author: Prof. Hywel Williams

Published in: American Journal of Clinical Dermatology | Issue 6/2011

Excerpt

This month’s issue of the American Journal of Clinical Dermatology sees the launch of a new and exciting section on evidence-based reviews, fronted by a systematic review of second-generation H₁-antihistamines in chronic urticaria by Kavosh and Khan.[1] The rationale for such a section deserves some further exploration by revisiting some of the basic tenets of evidence-based dermatology (EBD), systematic reviews, and comparative effectiveness research (CER), and what these mean for a practicing clinical dermatologist. …

Kavosh DR, Khan DA. Second generation H1-antihistamines in chronic urticaria: an evidence-based review. Am J Clin Dermatol 2011; 12 (6): 361–76PubMed

Williams HC, Bigby M. The rationale for evidence-based dermatology. In: Williams HC, Bigby M, Diepgen T, et al., editors. Evidence-based dermatology. 2nd ed. Oxford: Blackwell Publishing and BMJ Publishing Group, 2008

Mulrow CD. Rationale for systematic reviews. BMJ 1994; 309 (6954): 597–9PubMedCrossRef

Williams HC. Evidence-based dermatology: a bridge too far? Clin Exp Dermatol 2001; 26: 714–24PubMedCrossRef

Williams HC. Where do we go fromhere? In: Williams HC, Bigby M, Diepgen T, et al., editors. Evidence-based dermatology. 2nd ed. Oxford: Blackwell Publishing and BMJ Publishing Group, 2008

Richardson WS, Wilson MC, Nishikawa J, et al. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995; 123: A12–3

Relevo R, Balshem H. Finding evidence for comparing medical interventions: Agency for Healthcare Research and Quality (AHRQ) and the Effective Health Care program. J Clin Epidemiol. Epub 2011 Jun 16

Williams HC, Bigby M, Diepgen T, et al., editors. Evidence-based dermatology. London: BMJ Publishing Group, 2003

Dellavalle RP, Stegner DL, Deas AM, et al. Assessing evidence-based dermatology and evidence-based internal medicine curricula in US residency training programs: a national survey. Arch Dermatol 2003; 139: 369–72PubMedCrossRef

10.

Williams H. Applying the evidence back to the patient. Arch Dermatol 2003; 139: 1195–200PubMedCrossRef

11.

Eaglstein WH. Evidence-based medicine, the research-practice gap, and biases in medical and surgical decision making in dermatology. Arch Dermatol 2010; 146: 1161–4PubMedCrossRef

12.

Hajjaj FM, Salek MS, Basra MK, et al. Nonclinical influences, beyond diagnosis and severity, on clinical decisionmaking in dermatology: understanding the gap between guidelines and practice. Br J Dermatol 2010; 163: 789–99PubMedCrossRef

13.

Glasziou P, Irwig L, Bain C, et al. Systematic reviews in health care: a practical guide. New York (NY): Cambridge University Press, 2001: 137CrossRef

14.

Parker ER, Schilling LM, Diba V, et al. What’s the point of databases of reviews in dermatology if all they compile is “insufficient evidence”? J Am Acad Dermatol 2004; 50: 635–9PubMedCrossRef

15.

Smith EV, Grindlay DJ, Williams HC. What’s new in acne? An analysis of systematic reviews published in 2009-2010. Clin Exp Dermatol 2011; 36: 119–22PubMedCrossRef

16.

Jørgensen AW, Hilden J, Gøtzsche PC. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006; 333 (7572): 782CrossRef

17.

Trontell A. Comparative effectiveness 101 (with statistical applications). Center for Outcomes and Evidence, Agency for Health Care Research and Quality. 4th Annual FDA/DIA Statistics Forum, April 21, 2010 [online]. Available from URL: (http://www.fda.gov/downloads/Drugs/NewsEvents/UCM209104.pdf) [Accessed 2011 Jun 22]

18.

Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004; 364: p2188–95CrossRef

19.

Thomas K, Koller K, Dean T, et al. A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET). Health Technol Assess 2011; 15: 1–156

20.

Williams HC. Cars, CONSORT 2010 and clinical practice. Trials 2010 Mar 24; 11 (1): 33

21.

Moher D, Liberati A, Tetzlaff J, et al., The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6(7): e1000097

Title: Evidence-Based Dermatology
Everyone’s Business
Author: Prof. Hywel Williams
Publication date: 01-12-2011
Publisher: Springer International Publishing
Published in: American Journal of Clinical Dermatology / Issue 6/2011
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI: https://doi.org/10.2165/11595500-000000000-00000

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Evidence-Based Dermatology

Everyone’s Business

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2011

Second-Generation H1-Antihistamines in Chronic Urticaria

Primary Cutaneous Small- to Medium-Sized CD4+ Pleomorphic T-Cell Lymphoma

Botulinum Toxin for Glabellar Lines

Spotlight on Calcipotriene/Betamethasone Dipropionate in Psoriasis Vulgaris of the Trunk, Limbs, and Scalp

Acknowledgement

Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel